Title: Prohost Biotechnology :: News, Stocks, FDA Approvals, Clinical Trials
Description: Prohost evaluates biotechnology stocks and companies, their products technologies scientists and managers as well as finances.The Prohost Biotechnology Newsletter has been in circulation since 1992. Our readers are comprised of fund managers,investors,me
Keywords:
Biotechnology Newsletter,
FDA Approvals,
Biotechnology Stocks,
Agenus AGEN,
Abbott Laboratories ABT,
ADVENTRIX ANX,
Alnylam ALNY,
Amgen AMGN,
Anadys ANDS,
Ariad ARIA,
Array Pharmaceuticals ARRY,
Biogen Idec BIIB,
Bristol-Myers Squibb BMY,
CompuGen CGEN,
Cytokinetics CYTK,
Dendreon DNDN,
Dynavax DVAX,
Elan ELN,
Exelixis EXEL,
Genentech,
Gilead GILD,
GlaxoSmithKline GSK,
Human Genome Sciences HGSI,
Idenix IDIX,
Illumina ILMN,
ImmunoGen IMGN,
Incyte INCY,
Intermune ITMN,
ISIS,
KERYX KERX,
Merck MRK,
Micromet MITI,
Onyx ONXX,
OSI OSIP,
Prolor Biotech PBTH,
Regeneron REGN,
Roche RHHBY,
Sangamo SGMO,
Sanofi-Aventis SAN,
Seattle Genetics SGEN,
Sequenom SQNM,
SUNESIS PHARMACEUTICALS SNSS,
Valeant Pharmaceuticals International VRX,
Vertex VRTX,
XOMA(
View Less)
+
0%) - 
